×
About 105 results

ALLMedicine™ Menopausal Hormone Replacement Therapy Center

Research & Reviews  43 results

Primary Ovarian Insufficiency in women with Addison's disease.
https://doi.org/10.1210/clinem/dgab140
The Journal of Clinical Endocrinology and Metabolism; Vogt EC, Breivik L et. al.

Mar 9th, 2021 - Primary ovarian insufficiency (POI) is defined by menopause before 40 years of age. POI prevalence is higher among women with autoimmune Addison's disease (AAD) than in the general population, but their clinical characteristics are insufficiently ...

Controversies Regarding Post-Menopausal Hormone Replacement Therapy for Primary Cardiov...
https://doi.org/10.1097/CRD.0000000000000353
Cardiology in Review; Taylor JE, Baig MS et. al.

Nov 9th, 2020 - The debate over the safety and benefit of hormone replacement therapy (HRT) in postmenopausal women for primary prevention of cardiovascular disease has been ongoing for the past several decades. Observational trials in the 1980's suggested a bene...

2020 American College of Rheumatology Guideline for the Management of Reproductive Heal...
https://doi.org/10.1002/art.41191
Arthritis & Rheumatology (Hoboken, N.J.) References; Sammaritano LR, Bermas BL et. al.

Feb 24th, 2020 - To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medic...

Role of meprin metalloproteinases in cytokine processing and inflammation.
https://doi.org/10.1002/acr.24130
Cytokine Herzog C, Haun RS et. al.

Dec 23rd, 2018 - To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medic...

The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome
https://clinicaltrials.gov/ct2/show/NCT03436303

Feb 15th, 2018 - This is a prospective, open‑label, randomized controlled clinical trial compare the benefits and risks of half-dose or standard-dose conjugated equine estrogens(CEE) plus natural progesterone or dydrogesterone in menopausal hormone therapy during ...

see more →

Guidelines  3 results

2020 American College of Rheumatology Guideline for the Management of Reproductive Heal...
https://doi.org/10.1002/art.41191
Arthritis & Rheumatology (Hoboken, N.J.) References; Sammaritano LR, Bermas BL et. al.

Feb 24th, 2020 - To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medic...

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
https://jamanetwork.com/journals/jama/fullarticle/2665782
David C. Grossman

Dec 11th, 2017 - The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women. (D recommendation) The USPSTF recommends against the use of estrogen alone for the primary preventio.

Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/menopausal-hormone-therapy-preventive-medication1
US Preventive Services Task Force

Nov 30th, 2017 - The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal women. The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention.

see more →

Clinicaltrials.gov  55 results

Primary Ovarian Insufficiency in women with Addison's disease.
https://doi.org/10.1210/clinem/dgab140
The Journal of Clinical Endocrinology and Metabolism; Vogt EC, Breivik L et. al.

Mar 9th, 2021 - Primary ovarian insufficiency (POI) is defined by menopause before 40 years of age. POI prevalence is higher among women with autoimmune Addison's disease (AAD) than in the general population, but their clinical characteristics are insufficiently ...

Controversies Regarding Post-Menopausal Hormone Replacement Therapy for Primary Cardiov...
https://doi.org/10.1097/CRD.0000000000000353
Cardiology in Review; Taylor JE, Baig MS et. al.

Nov 9th, 2020 - The debate over the safety and benefit of hormone replacement therapy (HRT) in postmenopausal women for primary prevention of cardiovascular disease has been ongoing for the past several decades. Observational trials in the 1980's suggested a bene...

2020 American College of Rheumatology Guideline for the Management of Reproductive Heal...
https://doi.org/10.1002/art.41191
Arthritis & Rheumatology (Hoboken, N.J.) References; Sammaritano LR, Bermas BL et. al.

Feb 24th, 2020 - To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medic...

Younger Women Misinterpret Risks of HRT, Forgo Benefits
https://www.staging.medscape.com/viewarticle/907627

Jan 13th, 2019 - A new study examines in detail how and why the use of menopausal hormone replacement therapy (HRT) declined in the aftermath of the premature halting of the 2002 Women's Health Initiative (WHI) trial. The prevalence of prescription HRT declined im...

Younger Women Misinterpret Risks of HRT, Forgo Benefits
https://www.medscape.com/viewarticle/907627

Jan 13th, 2019 - A new study examines in detail how and why the use of menopausal hormone replacement therapy (HRT) declined in the aftermath of the premature halting of the 2002 Women's Health Initiative (WHI) trial. The prevalence of prescription HRT declined im...

see more →

News  4 results

Younger Women Misinterpret Risks of HRT, Forgo Benefits
https://www.staging.medscape.com/viewarticle/907627

Jan 13th, 2019 - A new study examines in detail how and why the use of menopausal hormone replacement therapy (HRT) declined in the aftermath of the premature halting of the 2002 Women's Health Initiative (WHI) trial. The prevalence of prescription HRT declined im...

Younger Women Misinterpret Risks of HRT, Forgo Benefits
https://www.medscape.com/viewarticle/907627

Jan 13th, 2019 - A new study examines in detail how and why the use of menopausal hormone replacement therapy (HRT) declined in the aftermath of the premature halting of the 2002 Women's Health Initiative (WHI) trial. The prevalence of prescription HRT declined im...

Menopausal Hormone Therapy Tied to Fecal Incontinence
https://www.staging.medscape.com/viewarticle/876206

Feb 23rd, 2017 - Use of menopausal hormone replacement therapy modestly raises the risk for fecal incontinence (FI), new research suggests. The findings, from nearly 56,000 postmenopausal women in the Nurses' Health Study, were published online February 13 in Gast...

Menopausal Hormone Therapy Tied to Fecal Incontinence
https://www.medscape.com/viewarticle/876206

Feb 23rd, 2017 - Use of menopausal hormone replacement therapy modestly raises the risk for fecal incontinence (FI), new research suggests. The findings, from nearly 56,000 postmenopausal women in the Nurses' Health Study, were published online February 13 in Gast...

see more →